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THE USE OF HEALTH ECONOMICS TERMINOLOGY IN CLINICAL 
PUBLICATIONS: BRIDGING THE GAP FROM CLINICAL EFFECTIVENESS 
TO COMPARATIVE EFFECTIVENESS
Reich S
PAREXEL, Hackensack, NJ, USA
OBJECTIVES: As the demands of the current regulatory climate and US Health Care 
Reform call for greater outcomes-based evidence in health care, the scientiﬁ c literature 
is increasingly incorporating pharmacoeconomic data into peer-reviewed clinical pub-
lications in order to demonstrate value to payer audiences. Data from clinical out-
comes and cost studies are increasingly ﬁ nding their way into traditional clinical 
papers and review articles. It has been observed that variations may exist in the use 
of health outcomes data and terminology. The purpose of this presentation will be to 
demonstrate how clearer and more consistent terminology can be integrated into 
scientiﬁ c publications and other vehicles in order to more effectively communicate 
economic and clinical outcomes information. METHODS: Using speciﬁ c examples 
from clinical publications, the presentation will: Identify and analyze common terms 
used for communicating health economic and outcomes research information to 
determine; If they have multiple and/or unclear meanings; How they are being used 
to convey information; Deﬁ ne the speciﬁ c meaning of these terms, using language that 
is understandable to all stakeholder audiences; Provide examples/case studies demon-
strating how more uniform and consistent deﬁ nitions can be integrated into payer-
focused clinical publications RESULTS: An overview of the ﬁ ndings regarding how 
to address speciﬁ c areas of confusion and inconsistency will be provided. CONCLU-
SIONS: The results will reiterate the need for clear and consistent terminology in 
communicating value in clinical publications.
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MOBILE MEDICAL RECORD—A LIFE SAVING TOOL
Friedman N, Goldberg A
Ben Gurion University of the Negev, Beer-Sheva, Israel
BACKGROUND: An emergency services team is launched to treat a man who col-
lapsed in the street. The team takes John Doe’s mobile phone, and within seconds 
retrieves the required clinical parameters from his Mobile Medical Record (MMR) 
thus providing a life-saving treatment suited to his personal health condition. Have 
the necessary clinical parameters, required at emergency situations, ever been exam-
ined in order to best match both emergency situations and cellular technology? 
OBJECTIVES: Characterization of the clinical parameters which assemble an MMR 
in the context of saving life and propose a model for an MMR in emergency medicine. 
METHODS: Characterization of the essential emergency medicine clinical parameters 
in the context of life-saving treatments, through interviews with prehospital and 
hospital experts in emergency medicine. Supported by a Cellular multimedia expert, 
analysis of the results in order to incorporate the clinical parameters into the cellular 
world as an MMR. RESULTS: Emergency medicine teams chose individual and 
speciﬁ c clinical parameters in a certain order of appearance from the general medical 
record which should assemble, in their opinion, emergency medicine MMR. MMR 
was chosen by the emergency medicine treatment teams as one of their preferred 
communication method among the possible communication methods presenting a 
patient medical record in the context of life-saving treatment. CONCLUSIONS: The 
MMR model, if applied correctly, will provide the emergency medicine treatment 
teams an available, reliable, homogeneous database of real time clinical parameters 
adapted to life-saving conditions. The MMR model represents a conceptual revolution 
of taking out the medical record from the caregiver and transferring it to the patient, 
which can be constantly at hand at any given time or place. By doing so, the MMR 
contributes and becomes integrated with the leading approaches in the world of 
medicine supporting a patient-centered care policy.
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CURRENT TRENDS IN HEALTH TECHNOLOGY INCORPORATION (HTI) 
IN BRAZIL: INSIDE THE NATIONAL HEALTH SYSTEM’S (NHS) BLACK 
BOX
Teich V1, Costa ALMA1, Cunha TMB1, Clark LGO2
1MedInsight-Evidências, Rio de Janeiro, Brazil; 2MedInsight-Evidências, Campinas, Brazil
OBJECTIVES: We aimed to evaluate the trends of submissions and recommendations 
received and emitted by the Brazilian Commission on Health Technology Incorpora-
tion (CITEC) during the process of adoption/exclusion of technologies on the coun-
try’s Public Health System and to critically appraise this process and to analyze the 
challenges this commission faces in responding to the increased demand for incorpora-
tion of new technologies. METHODS: All submissions on health technologies made 
to CITEC and the respective responses obtained between 2003 and 2010 were 
reviewed. They were classiﬁ ed by ﬁ eld of interest, origin of request and type of 
response. RESULTS: During the selected period CITEC received 222 proposals for 
technology incorporation and produced 83 recommendations. We identiﬁ ed an 
increase in submissions after 2007. From 2003 to 2006, only 39 requests were submit-
ted on total. After 2007, an average of 49 submissions per year was made. The main 
ﬁ elds were endocrine and metabolic disorders (12%), Oncology (11%) and Rheuma-
tology (11%), but the percentage of responses in these ﬁ elds was low (34%, 8% and 
28% respectively). More than 70% of the submissions were commissioned by the 
Industry (162), but only 27% of these were answered. However, almost all submis-
sions sent directly by the Ministry of Health were answered (94%). Among recom-
mendations from CITEC, 53% were favorable to the incorporation of the new 
technology and 30% were contrary to it, 17% were cancelled submissions. Adopted 
technologies were mainly for hepatitis (14%), endocrine and metabolic disorders 
(11%) and genetic disorders (11%). CONCLUSIONS: Although there isn’t a clear 
deﬁ nition of priorities for the incorporation of new technologies by the Brazilian 
Ministry of Health, it is possible to map trends in the recommendations issued by 
CITEC. It is of the utmost importance to achieve greater disclosure of the criteria for 
selection of technologies for incorporation by the Commission.
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PREDICTING OUTCOMES AMONG PATIENTS WITH PROLONGED 
MECHANIC VENTILATION: A DISCRIMINATION MODEL BASED ON 
LONGITUDINAL HEALTH INSURANCE REGISTRATION AND CLAIMS 
DATA
Lu HM1, Chen L1, Hung MC2, Wang JD2, Lin MS3, Yan YH3, Chen CR3, Fan PS3, Kuo KN1
1National Health Research Institutes, Zhunan, Taiwan; 2National Taiwan University, Taipei, 
Taiwan; 3Chia-Yi Christian Hospital, Chiayi, Taiwan
OBJECTIVES: To identify patients with low survival probability among those with 
prolonged mechanical ventilation (PMV; >=21 days of use) under the Taiwan National 
Health Insurance (NHI), and explore the length of their time free of inpatient mechani-
cal ventilation (MV) and MV-related hospital expenses during the four years following 
PMV. METHODS: This is a retrospective cohort study using death certiﬁ cates data 
and longitudinal NHI data for a national representative sample of 25,482 new PMV 
patients in 1998–2003. Logit regression was used to determine factors associated with 
3-month, 6-month, 1-year and 2-year survival. Explanatory factors included hospital 
characteristics, and individual demographics, socioeconomic conditions, diseases at 
the PMV onset, and diseases causing hospital care use within the year before PMV. 
The probability cutoff was set at 10% for identifying patients with low survival likeli-
hood and suitable as targets of advocating less intensive care. RESULTS: Five disease 
types had high prevalence, and were signiﬁ cantly associated with lower survival: 
septicemia, neoplasm, shock, acute and unspeciﬁ c renal failure, and chronic renal 
failure. Each had an odds ratio <0.65 (p < 0.001). Non-alcohol-related liver disease 
was also a signiﬁ cant problem. Each survival model had a C-statistic >= 0.7. At the 
10% probability cutoff, 1.5%, 5.1%, 11.9% and 21.8% of PMV patients were identi-
ﬁ ed as negative cases for 3-month, 6-month, 1-year and 2-year survival. The negative 
predictive values were 86.5%, 86.1%, 89.4%, and 91.8%, respectively. During the 
four years after PMV, 75% of these patients had 25 or fewer days free of MV-related 
hospital care, and more than 50% of them spent at least 10,800 dollars (2010 USD) 
on MV-related hospital care. CONCLUSIONS: This discrimination model has accept-
able performance. It helps in selecting potential targets for advocating less intensive 
care, and also generates more empirical evidence on prognosis that can facilitate 
patient-clinician and family-clinician communication.
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ANALYSIS THE AVERAGE SOJOURN TIME AND BOTTLENECK AFTER A 
DISASTER IN HOSPITALS
Sakata K1, Kobayashi D2, Matsui M1
1The University of Electro-Communications, Chofu, Tokyo, Japan; 2The University of 
Electro-Communications, Minato-ku, Tokyo, Japan
OBJECTIVES: The purpose of this study is to consider the average sojourn time of 
patients ﬁ gure out hospital’s function after a disaster striking. METHODS: This study 
explores the average sojourn time of patients and bottleneck in hospitals in the region 
deﬁ ned by this study. Especially, we focus on three days after a disaster striking the 
region. We deﬁ ned three scenarios. • Scenario I:Hospital No.II ceases to function two 
days from disaster strikes. • ScenarioII:Hospital No.II ceases to function one day from 
disaster strikes. • ScenarioIII:ScenarioIII is the same scenario as the scenario I, but 
considering transport from break down hospital (hospital No.2) to hospitals in opera-
tion. Patient’s arrival interval λand treatment time μ are equal to the data of Hanshin 
earthquake. With the use of those scenarios, we analyze the average sojourn time of 
patients and bottleneck with a queuing approach, critical path method and little’s law. 
In addition to that, we make Cumulative ﬂ ow graph to analyze bottleneck. RESULTS: 
Comparing scenario I and scenario III, the average sojourn time of general hospital of 
scenario III is longer than scenario I, although scenario III has more choices. It reveals 
considering transport from break down hospitals to hospitals in operation extends the 
average sojourn time. We observed bottleneck in case of changing patient’s arrival 
interval λ by making cumulative ﬂ ow graph. This study shows cumulative ﬂ ow graph 
reveals status of hospital’s function after a disaster. CONCLUSIONS: The results 
conﬁ rm that the average sojourn time of patients increase in case of changing hospital, 
Braess’s paradox and cumulative ﬂ ow graph reveals status of hospital’s function after 
a disaster.
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CONTENT OF HOME PHARMACIES IN SERBIA
Paut Kusturica M1, Sabo A2, Tomic Z2, Stilinovic N2
1A.D. Sanitarija, Novi Sad, Serbia; 2Faculty of Medicine, Novi Sad, Serbia
OBJECTIVES: To get insight into the amount, structure and ﬁ nancial aspects of 
medicines in home pharmacies as well as learning about the population’s attitudes, 
habits and knowledge concerning self-medication. METHODS: This survey was con-
ducted in the ﬁ rst half of 2010. on a sample of 50 families on the territory of Novi 
Sad, Serbia. The families were chosen randomly and the data were collected by using 
the standardized questionnaire and checking the inventory of medicines. RESULTS: 
The average number of packets in home pharmacies per a family is considerable (13 
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packets). The most widely kept medicines are medicines for the central nervous system 
(21%), the disorders in the digestive system and metabolism (16.7%) and medicines 
for the diseases of the respiratory system (14.5%). Nearly three-fourths of opened 
packets were not entirely consumed. a large number of medicines in home pharmacies 
(79%) was obtained self initiatedly and many of them were beyond their expiry date 
(9.5%). a total of 25% of the ﬁ nancial means for those medicines was provided from 
health insurance funds. The total cost of medicines in home pharmacies per a family 
in Serbia was c25.13. a total of 72% of that amount was paid by the patients 
themselves. Pharmacoeconomic indicators in certain groups of medicines show that 
the largest percentage of the ﬁ nancial means for home pharmacies in Serbia is spent 
on the medicines for gastrointestinal problems and metabolism disorders (17%). 
CONCLUSIONS: Based on the analyzed data, self-medication, that is, unreasonable 
use of medicines, is a big problem in Serbia. The use of these medicines involves the 
risk of inadequate treatment of the illness, frequent occurrence of side-effects which 
sometimes requires additional treatment, which only increases the expenses for both 
the patients and health funds. Therefore, it is necessary to closely monitor the issuing 
of prescriptions as well as educate the population.
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PRIMARY HEALTH CARE AND POTENTIALLY AVOIDABLE 
ADMISSIONS: A 10-YEAR ASSESSMENT FROM THE PERSPECTIVE OF A 
HEALTH CARE PLAN
Reis Neto J, Tovar C
CAPESESP/CAPESAUDE, Rio de Janeiro, RJ, Brazil
OBJECTIVES: To examine the evolution of the rate of admissions for ambulatory 
care sensitive conditions in beneﬁ ciaries of a health care plan, monitoring of access to 
the health system and its performance and identifying strategies that will enable the 
improvement of the health situation of the population and the appropriate allocation 
of resources. METHODS: Retrospective analysis of 212,360 hospital admissions, 
occurring between 1999 and 2008, among beneﬁ ciaries of a health care plan, resident 
in Brazil. The outcome of the study was the proportion of admissions for primary 
care sensitive conditions, identiﬁ ed by ICD-10. The proportion of these admissions in 
relation to the total hospital admissions was established, as well as the quotient for 
the number of hospital admissions and the population, either total or by age group 
and speciﬁ c causes, besides hospital direct costs. The signiﬁ cance was tested and 
estimates of the rates were deﬁ ned based on their 95% conﬁ dence intervals. RESULTS: 
Admissions for primary care sensitive conditions accounted for 55,307 of 212,360 
admissions reimbursed by the health plan (26.0%). The rate of admission for primary 
care sensitive conditions fell by 28.0% during the period (from 347.6 to 250.3 per 10 
thousand). The most frequent cause was gastroenteritis (30.9%), followed by arterial 
hypertension (13.6%), cerebrovascular diseases (9.6%), heart failure (8.1%), kidney 
and urinary tract infections (6.8%), diabetes mellitus (5.8%) and angina pectoris 
(5.5%). The mean annual expenditure on admissions was R$15,232,494 against 
R$51,440,680 for other conditions (22.8%). CONCLUSIONS: The reduction 
observed in the rate of admissions for primary care sensitive conditions suggests pos-
sible improvements in primary health care. Further actions and strategies could reduce 
the number of avoidable admissions and contribute to the ﬁ nancial balance of the 
health care plan.
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EVALUATION OF THE IMPACT OF INPATIENT CLINICAL PHARMACY 
SERVICES ON THE QUALITY AND COST OF PHARMACOTHERAPY IN 
INTERNAL MEDICINE WARDS
Pitakthum S
Songkhla Hospital, Songkhla, Thailand
OBJECTIVES: The purpose of this longitudinal descriptive study was to evaluate the 
inﬂ uence of interventions by clinical pharmacists on processes, outcomes of care and 
economical outcomes. METHODS: The patients who were hospitalized at internal 
medicine wards, Songkhla hospital during October 1, 2008-September 30, 2009 were 
recruited to this study. The core set of clinical pharmacy services were admission drug 
histories, drug protocol management, adverse drug reaction management, drug infor-
mation, medical rounds and patient discharge counseling. The clinical pharmacists 
collected patients’ data, pharmacists’ interventions, direct drug cost-saving and activi-
ties on a speciﬁ c designated form. The data was processed on a computerized database. 
Clinical pharmacist interventions were counted and classiﬁ ed and analyzed to deter-
mine the inﬂ uence on the quality and cost of pharmacotherapy. Descriptive statistics 
were used in data analysis. RESULTS: At the end of the study period the following 
were found: a total of 3796 patients were recruited. Clinical pharmacy services on 
internal medicine wards contribute to maximizing the pharmacotherapeutic effect and 
rationalization of drug therapy in 609 patients (16.0%), increase medication safety in 
338 patients (8.9%) and reducing drug expenditures in 575 patients (15.1%). Cost-
saving from reconciling process was US$12,682 and cost-saving from pharmacists’ 
interventions were US$6,298. The frequent type of interventions was maximizing the 
pharmacotherapeutic effect (40.8%), rationalization of drug therapy (30.3%) and 
minimizing the risk for developing adverse drug effects (28.9%), respectively. The top 
two of drug related problems found in cardiovascular drugs (30.5%) and antibiotic 
drugs (24.8%), respectively. CONCLUSIONS: The results of this study indicate that 
inpatient clinical pharmacy services on internal medicine wards contribute to ratio-
nalization of drug therapy, increase medication safety and reduced the direct expen-
ditures on medications. Therefore, future studies should include multiple sites such as 
in a general surgical department and clinical pharmacy services should be 
continued.
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ALLOCATION OF A SINGLE BUDGET FOR HEALTH CARE, 
PROFESSIONAL EDUCATION, AND RESEARCH
Gandjour A
Pennington Biomedical Research Center/Louisiana State University, Baton Rouge, LA, USA
OBJECTIVES: Funding for health care programs competes with funding for professional 
education (ie, implementation of health care programs) and funding for research to 
reduce uncertainty around program cost-effectiveness. No study has yet shown how to 
allocate a combined budget for health care, professional education, and research. Previ-
ous work did not consider the fundamental idea that interventions with an acceptable 
incremental cost-effectiveness ratio (ICER) for an adoption decision may not be accept-
able any more once implementation decisions are made simultaneously. Furthermore, 
previous work did not consider that cost-effectiveness of research is conditional upon 
the programs chosen for adoption and implementation. The purpose of this work is to 
present a sequential process to allocate a combined budget with the goal to maximize 
health. METHODS: Development of a 3-step allocation process to maximize health 
based on a single budget for health care, professional education, and research RESULTS: 
As a ﬁ rst step, a league table approach determines which programs would be funded if 
the combined budget were spent just on adoption. The second step analytically deter-
mines a new (lower) threshold ICER which maximizes health by discontinuing programs 
above the new threshold and investing in implementing programs below the threshold. 
The third step considers cost-effectiveness of research to reduce uncertainty around 
program cost-effectiveness. In order to fund this research, the threshold ICER for adop-
tion plus implementation has to be reduced further. In order to maximize health, ICERs 
of research studies need to equal the newly deﬁ ned threshold ICER for adoption plus 
implementation. CONCLUSIONS: A 3-step allocation process is able to maximize 
health based on a single budget for health care, professional education, and research. 
Compared to a programming approach the proposed approach yields a closed-form 
analytical solution and is able to consider that research decisions are conditional upon 
adoption and implementation choices.
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DIRECT CONTRACTS ON PATENT-PROTECTED PHARMACEUTICALS 
IN GERMANY: MOTIVES OF SICK FUNDS AND PHARMACEUTICAL 
COMPANIES
Neurohr C, Huebner S, Ernst F, Welte R
GlaxoSmithKline GmbH & Co. KG, Munich, Germany
OBJECTIVES: To investigate the motives of both contracting parties, sick funds and 
pharmaceutical companies, to enter into direct contracts on patent-protected pharma-
ceuticals in the outpatient sector in Germany. METHODS: A systematic literature 
review was performed in March 2010 to identify contracts on patent-protected phar-
maceuticals in Germany. Standard literature databases such as Pubmed and EMBASE, 
different market research databases and the ‘Lauer-Taxe’, the ofﬁ cial German price 
registry for pharmaceuticals were utilised. We included only ofﬁ cially reported contracts. 
a detailed market analysis was conducted to identify the motives of the identiﬁ ed con-
tracts. RESULTS: The number of direct contracts has been recently increasing. a total 
of 116 contracts were found. Formally, they are all rebate contracts due to German law. 
However, they include risk-sharing (n = 6), cost-sharing (2), added value (5) and simple 
rebate contracts (103). For sick funds, major motives were cost cutting, positioning 
within the market, attracting the “right” members, improving the medical treatment 
and right coding. Pharmaceutical companies show several motives that can be clustered 
into proactive and reactive motives: Proactive motives were: gaining access to reimburse-
ment beyond standard coverage, funding of managed care concepts, bridging a time gap 
until market entry of a successor, maintaining the attractiveness after patent expiration 
as well as shaping the market access environment. Reactive motives were: rebate con-
tracts of competitors, limitations and exclusions from reimbursement by the federal joint 
committee as well as reacting to attempts by sick funds and Associations of Statutory 
Health Insurance Physicians to control drug expenditures. CONCLUSIONS: Direct 
contracting on patent-protected pharmaceuticals seems to play a increasing role in the 
strategic considerations of pharmaceutical companies and sick funds.
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A TALE OF FOUR COUNTRIES: COMPARING REIMBURSEMENT 
SUBMISSION REQUIREMENTS IN IRELAND, ENGLAND, WALES AND 
SCOTLAND
Rycroft C1, Pearson I1, Khan S2, Heyes A1
1RTI Health Solutions, Manchester, UK; 2RTI Health Solutions, Research Triangle Park, NC, 
USA
OBJECTIVES: Requirements for a Health Technology Assessment (HTA) submission vary 
within the UK (England and Wales [National Institute for Health and Clinical Excellence 
(NICE)], Scotland [Scottish Medicines Consortium (SMC)], and Wales [All Wales Medi-
cines Strategy Group (AWMSG)]) and the Republic of Ireland (National Centre for 
Pharmacoeconomics [NCPE]). The objective of this study is to determine whether the 
likelihood of reimbursement in these markets is linked to HTA submission requirements. 
METHODS: Dossier requirements issued by NCPE, NICE, SMC and AWMSG were 
compared, and a checklist of requirements compiled. We investigated 20 interventions 
most recently reviewed by the NCPE, and recorded the recommendations for these com-
pared with those issued by NICE, SMC and AWMSG. RESULTS: Economic analysis is 
key for an NCPE submission, although there are no speciﬁ c requirements or template for 
the clinical data. Requirements for NICE are the most stringent; SMC and AWMSG have 
similar requirements. Of 20 interventions reviewed by NCPE, 11 (55%) were reimbursed 
